Axsome Therapeutics, Inc. (AXSM)
164.82
+0.77
(+0.47%)
USD |
NASDAQ |
Mar 04, 10:47
Axsome Therapeutics Cash from Investing (TTM) : -0.48M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 69.76M |
| Gilead Sciences, Inc. | -4.793B |
| Vanda Pharmaceuticals, Inc. | 94.86M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Amicus Therapeutics, Inc. | -46.43M |